AnalystBook Research · Company Intelligence

GUIDED THERAPEUTICS INC

GTHPOTC

Built from GUIDED THERAPEUTICS INC's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

  • Earnings-manipulation signal · Beneish M 87.01 flag raised, worth a closer lookWatch
  • Earnings quality 80/100 accruals in line with cashOK

Latest filings

  • 10-Q · Quarterly report2026-08-13
  • 10-Q · Quarterly report2026-05-15
  • 10-K · Annual report2026-03-31
  • 8-K · Company announcement2026-03-10
  • 10-Q · Quarterly report2025-11-13
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about GUIDED THERAPEUTICS INC, every answer cited to the official filings🔒
  • The Intelligence Brief — added when GUIDED THERAPEUTICS INC's brief passes our SEC-figure check🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.